Skip to main content
. 2016 Oct 31;2016(10):CD010683. doi: 10.1002/14651858.CD010683.pub3

8. Vascular occlusion methods: choice of model results.

Serious adverse events (proportion)
Treatment number Treatment name
1 Control
2 ConHVE
3 ConPTC
4 ConSelectiveHVE
5 ConSelectivePTC
6 IntPTC
  Fixed‐effect model Random‐effects model Inconsistency model
Dbara 64.25 63.57 64.03
pDb 12.54 14.37 14.83
DICc 76.79 77.95 78.86
d[2]d 0.82 (95% CrI −1.70 to 3.50) 0.62 (95% CrI −5.00 to 5.89)
d[3]e 0.35 (95% CrI −1.26 to 1.96) 0.16 (95% CrI −3.87 to 3.71)
d[4]f −1.98 (95% CrI −8.24 to 1.48) −2.25 (95% CrI −9.99 to 3.38)
d[5]g −0.63 (95% CrI −2.29 to 0.97) −1.01 (95% CrI −5.35 to 2.36)
d[6]h 0.15 (95% CrI −0.61 to 0.92) −0.07 (95% CrI −2.53 to 1.85)
Between‐study standard deviation 1.216
Model used Fixed‐effect model  
Evidence of inconsistency There is no evidence of inconsistency since the difference in DIC between consistency and inconsistency models was not significant.
 
Adverse events (proportion)
Treatment number Treatment name
1 Control
2 ConHVE
3 ConPTC
4 ConSelectiveHVE
5 ConSelectivePTC
6 IntPTC
7 IntSelectivePTC
  Fixed‐effect model Random‐effects model Inconsistency model
Dbara 120.82 118.76 119.07
pDb 18.10 21.01 21.93
DICc 138.92 139.77 141.00
d[2]d 0.95 (95% CrI −0.21 to 2.12) 0.90 (95% CrI −1.12 to 2.84)
d[3]e 0.83 (95% CrI 0.00 to 1.69) 0.78 (95% CrI −0.58 to 2.09)
d[4]f 0.05 (95% CrI −1.19 to 1.27) 0.00 (95% CrI −2.05 to 1.96)
d[5]g 0.10 (95% CrI −0.81 to 1.01) 0.07 (95% CrI −1.42 to 1.50)
d[6]h 0.24 (95% CrI −0.19 to 0.68) 0.18 (95% CrI −0.66 to 0.88)
d[7]i 0.09 (95% CrI −0.75 to 0.93) 0.04 (95% CrI −1.37 to 1.35)
Between‐study standard deviation 0.4825
Model used Fixed‐effect model  
Evidence of inconsistency There is no evidence of inconsistency since the difference in DIC between consistency and inconsistency models was not significant.
Blood transfusion (proportion)
Treatment number Treatment name
1 Control
2 ConHVE
3 ConPTC
4 ConSelectiveHVE
5 ConSelectivePTC
6 IntPTC
7 IntSelectivePTC
  Fixed‐effect model Random‐effects model Inconsistency model
Dbara 139.87 120.00 120.10
pDb 19.04 25.25 25.72
DICc 158.91 145.25 145.82
d[2]d −2.55 (95% CrI −3.80 to −1.36) −2.88 (95% CrI −7.47 to 1.47)
d[3]e −0.77 (95% CrI −1.56 to 0.01) −1.11 (95% CrI −3.72 to 1.28)
d[4]f −1.46 (95% CrI −2.58 to −0.36) −1.79 (95% CrI −6.38 to 2.53)
d[5]g −0.26 (95% CrI −1.18 to 0.67) −0.48 (95% CrI −3.83 to 2.72)
d[6]h −0.34 (95% CrI −0.84 to 0.16) −0.47 (95% CrI −2.32 to 1.28)
d[7]i −0.92 (95% CrI −1.96 to 0.08) −0.97 (95% CrI −4.24 to 2.24)
Between study standard deviation 1.613
Model used Random‐effects model
Evidence of inconsistency There is no evidence of inconsistency since the difference in DIC between consistency and inconsistency models was not significant.
Blood transfusion (red blood cell) (units)
Treatment number Treatment name
1 Control
2 ConHVE
3 ConPTC
4 ConSelectiveHVE
5 ConSelectivePTC
6 IntPTC
7 IntSelectivePTC
  Fixed‐effect model Random‐effects model Inconsistency model
Dbara −1.55 −1.05 0.24
pDb 15.99 17.36 19.34
DICc 14.44 16.32 19.58
d[2]d −1.65 (95% CrI −3.96 to 0.67) −1.56 (95% CrI −4.18 to 1.14)
d[3]e −1.25 (95% CrI −2.39 to −0.10) −1.18 (95% CrI −2.54 to 0.31)
d[4]f −2.45 (95% CrI −4.08 to −0.82) −2.37 (95% CrI −4.33 to −0.30)
d[5]g −1.45 (95% CrI −2.59 to −0.31) −1.41 (95% CrI −2.86 to 0.12)
d[6]h −1.36 (95% CrI −2.48 to −0.23) −1.35 (95% CrI −2.69 to 0.01)
d[7]i −1.43 (95% CrI −2.61 to −0.24) −1.43 (95% CrI −3.01 to 0.08)
Between‐study standard deviation 0.3149
Model used Fixed‐effect model  
Evidence of inconsistency There is no evidence of inconsistency since the difference in DIC between consistency and inconsistency models was not significant.
Blood loss (litres)
Treatment number Treatment name
1 Control
2 ConHVE
3 ConPTC
4 ConSelectiveHVE
5 ConSelectivePTC
6 IntPTC
7 IntSelectivePTC
  Fixed‐effect model Random‐effects model Inconsistency model
Dbara −45.73 −61.66 −63.13
pDb 22.01 29.37 30.58
DICc −23.72 −32.29 −32.55
d[2]d −0.36 (95% CrI −0.50 to −0.23) −0.37 (95% CrI −0.94 to 0.22)
d[3]e −0.02 (95% CrI −0.12 to 0.07) −0.14 (95% CrI −0.52 to 0.14)
d[4]f −0.27 (95% CrI −0.54 to −0.01) −0.39 (95% CrI −1.16 to 0.27)
d[5]g 0.09 (95% CrI −0.04 to 0.21) 0.00 (95% CrI −0.57 to 0.45)
d[6]h 0.01 (95% CrI −0.05 to 0.07) −0.06 (95% CrI −0.39 to 0.17)
d[7]i 0.00 (95% CrI −0.21 to 0.2) −0.18 (95% CrI −0.84 to 0.30)
Between‐study standard deviation 0.2539
Model used Random‐effects model
Evidence of inconsistency There is no evidence of inconsistency since the difference in DIC between consistency and inconsistency models was not significant.
Con: continuous; Int: intermittent; HVE: hepatic vascular exclusion; PTC: portal triad clamping.

aDBar = posterior mean of deviance.
 bpD = effective number of parameters.
 cDIC = deviance information criterion.
 dd[2] indicates effect estimate (mean difference) of treatment 2 versus treatment 1.
 ed[3] indicates effect estimate (mean difference) of treatment 3 versus treatment 1.
 fd[4] indicates effect estimate (mean difference) of treatment 4 versus treatment 1.
 gd[5] indicates effect estimate (mean difference) of treatment 5 versus treatment 1.
 hd[6] indicates effect estimate (mean difference) of treatment 6 versus treatment 1.
 id[7] indicates effect estimate (mean difference) of treatment 7 versus treatment 1.